Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin for Influenza and ARVI in Children 7-12 Years Old
NCT03191097Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza and acute respiratory viral infection (ARVI) comparing Ingavirin with Placebo (2 arms). Primary endpoint: Time to resolution of fever at 7 days. Started Aug 2014; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03191097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03191097.